-
share some
features with
RASopathies but are not
considered true
RASopathies if
caused by
somatic mutation. Generally,
RASopathies increase the risk of developing...
- (CFC)
syndrome is an
extremely rare
genetic disorder, and is one of the
RASopathies. It was
first described in 1986. It is
characterized by the following:...
-
constitutively active.
Trametinib has been used off
label to
treat various RASopathies,
including Noonan Syndrome and
Primary Intestinal Lymphangiectasia. "Prescription...
- with
intellectual disability, neuro-cardio-facial-cutaneous syndromes,
RASopathies,
ectodermal dysplasias, and
certain myopathies.
Physicians can often...
-
indicative of schwannomatosis. The
neurofibromatoses are
considered as
RASopathies and as
members of the
neurocutaneous syndromes (phakomatoses). The diagnosis...
- RAS
components of the MAP/ERK
signal transduction pathway are
called RASopathies. J****
kinase Phosphatase Signal transducing adaptor protein G protein-coupled...
-
constant and the
occurrence of
renal abnormalities is much lower.
Other RASopathies Watson syndrome -
Watson Syndrome has a
number of
similar characteristics...
-
disease in the
RASopathy family of diseases,
which include Costello Syndrome,
Noonan Syndrome, and
Cardiofaciocutaneous syndrome. The
RASopathies also present...
- Saunders. ISBN 0-7216-2921-0.
Tidyman WE,
Rauen KA (June 2009). "The
RASopathies:
developmental syndromes of Ras/MAPK
pathway dysregulation". Current...
- Washington, Seattle. PMID 20301450.
Tidyman WE,
Rauen KA (June 2009). "The
RASopathies:
developmental syndromes of Ras/MAPK
pathway dysregulation". Current...
